The Sky Shop for Hope

The Sky Shop for Hope is more than just a store—it’s a movement fueled by compassion and the determination to make a difference in the fight against pancreatic cancer. Every purchase you make supports groundbreaking research, with profits from of all proceeds benefitting the Sky Foundation, a 501(c)3 organization that funds efforts to save lives and bring hope to countless families.

Monthly Giving Mystery Boxes

Turn your giving into a monthly experience.
When you partner with Sky Foundation, you’re not just supporting life-changing pancreatic cancer research—you’re joining a movement. Each month, you’ll receive a surprise package in the mail, a tangible reminder of the hope and progress you’re fueling. Fun, meaningful, and impactful—all in one.

Pet Products!

Spoil your pets with goodies that make a difference. Our products benefit the Sky Foundation and help fund pancreatic research.

View all

Custom Pickleball Sets

View all

Empowerment Journals

View all

Limited Edition Phone Cases

View all

More Product Categories

View all

PC in the news

View all
  • Phase 1/2 Trial Launches for Innovative Pancreatic Cancer Immunotherapy

    Phase 1/2 Trial Launches for Innovative Pancrea...

    UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...

    Phase 1/2 Trial Launches for Innovative Pancrea...

    UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...

  • FDA Approves NALIRIFOX as First-Line Treatment for Metastatic Pancreatic Cancer

    FDA Approves NALIRIFOX as First-Line Treatment ...

    New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...

    FDA Approves NALIRIFOX as First-Line Treatment ...

    New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...

  • Immunotherapy for Pancreatic Ductal Adenocarcinoma: Barriers and Opportunities

    Immunotherapy for Pancreatic Ductal Adenocarcin...

    Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...

    Immunotherapy for Pancreatic Ductal Adenocarcin...

    Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...

  • Pancreatic Cancer Vaccine Shows Early Promise in Preventing Recurrence

    Pancreatic Cancer Vaccine Shows Early Promise i...

    UCLA’s Dr. Zev Wainberg discusses results from the AMPLIFY-201 trial and hopes for next-generation vaccines. Researchers are exploring new ways to fight pancreatic cancer, one of the toughest cancers to...

    Pancreatic Cancer Vaccine Shows Early Promise i...

    UCLA’s Dr. Zev Wainberg discusses results from the AMPLIFY-201 trial and hopes for next-generation vaccines. Researchers are exploring new ways to fight pancreatic cancer, one of the toughest cancers to...

1 4
View all